Ascentage Pharma Group International (OTCMKTS:ASPHF) Sees Significant Decline in Short Interest

Ascentage Pharma Group International (OTCMKTS:ASPHF) was the recipient of a large decrease in short interest in the month of February. As of February 15th, there was short interest totalling 1,620,800 shares, a decrease of 16.7% from the January 31st total of 1,946,100 shares. Based on an average daily volume of 100 shares, the short-interest ratio is currently 16,208.0 days.

Ascentage Pharma Group International Price Performance

Shares of Ascentage Pharma Group International stock opened at $5.83 on Wednesday. The company has a fifty day moving average price of $6.05 and a 200 day moving average price of $5.15. Ascentage Pharma Group International has a twelve month low of $5.42 and a twelve month high of $6.45.

About Ascentage Pharma Group International

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.